LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17496233

Download in:

View as

General Info

PMID
17496233